NKB Regovanta simplifies compliance with stringent EU medical device requirements under the Medical Devices Regulation (EU 2017/745) and In Vitro Diagnostic Regulation (EU 2017/746). We expertly guide manufacturers through Notified Body conformity assessments, CE technical documentation, EUDAMED registration, and the seamless transition from legacy directives to the new regulatory landscape.
Compliance for Medical Device Registration & Regulation Landscape in EU
The European Union stands as one of the most rigorously regulated, yet commercially vital, medical device markets globally. Encompassing 27 member states, alongside 3 EEA nations and Turkey, the Union market operates under a strictly harmonized regulatory ecosystem. This framework, defined by the EU MDR (2017/745) for medical devices and the EU IVDR (2017/746) for in vitro diagnostics, mandates uniform safety and performance benchmarks across all product categories.
To legally introduce a device into the Union market, manufacturers are required to secure CE marking. This certification serves as a formal declaration of compliance with applicable regulations, contingent upon the device’s specific risk classification and the appropriate conformity assessment route. Non-compliance carries severe repercussions, potentially resulting in product recalls, customs seizures, suspension of existing certifications, or a total loss of market access privileges.
Under the current EU Regulatory regime:
CE marking is strictly mandatory for all medical devices and IVDs prior to commercialization within the region.
EUDAMED device registration is actively being implemented in phased rollouts, with multiple modules already designated for mandatory use.
European Authorised Representative (EAR) appointment is legally obligatory for any manufacturing entity located outside the EU/EEA/Turkey jurisdictions.
Stringent MDR/IVDR classification rules necessitate highly robust technical documentation, definitive clinical or performance evidence, and active, continuous lifecycle monitoring.